British teenager dies after HPV Vaccination

COVENTRY, UK, SEPTEMBER 29, 2009—A14-YEAR-OLD died hours after receiving the controversial cervical cancer vaccine

Natalie Morton, a student of the Blue Coat Church of England School in Coventry was given Glaxo SmithKline’s Cervarix as part of the UK National Health Service’s (NHS) immunization program directed at teenage girls with the purpose of protecting them against strains of the human papillomavirus (HPV), a sexually transmitted disease.

Adding to the 2,137 reports of adverse effects following vaccination since April, health officials remain uncertain of Morton’s case whether the student had an extreme reaction to a standard vaccine, or whether the particular dose she was given was from a “rogue contaminated batch.”

Either situation raises serious questions about the safety of the vaccine.

Dr. Caron Grainger, director for public health at Coventry city council, said an autopsy will be conducted to investigate if the vaccine played a role in Natalie’s death.

Mike Attwood, a spokesman for Coventry Primary Care Trust said: “An urgent investigation has been launched and while we wait for the results from the post mortem all vaccinations using the drug have been temporarily stopped.”

The National Vaccine Information Centre (NVC), a private vaccine-safety group based in the US, reported that from 2006 as many as 11,900 girls and young women had reported adverse events after receiving the Gardasil vaccine, which is manufactured by Merck Pharmaceutical for use in the US and Canada.

These adverse events included such mild reactions as pain, fever, nausea, dizziness and itching, to serious effects such as Bells Palsy, Guillain-Barre Syndrome, and seizures. The number of deaths associated with the Gardasil vaccine by the NVC is between 32 and 45 in the US alone.

Credits:
Cited from an original article by Thaddeus M. Baklinski for lifesitenews.com last 09/29/09